Tao Sun

Active 1989–2027

1,870
Papers
102,997
Citations
155
h-index
1,224
i10-index

Citations

Citations per year for Tao Sun1969: 1 citations1971: 1 citations1979: 1 citations1984: 1 citations1989: 1 citations1990: 3 citations1991: 3 citations1992: 2 citations1993: 6 citations1994: 2 citations1995: 4 citations1996: 5 citations1997: 8 citations1998: 6 citations1999: 16 citations2000: 20 citations2001: 38 citations2002: 92 citations2003: 73 citations2004: 95 citations2005: 113 citations2006: 138 citations2007: 142 citations2008: 154 citations2009: 181 citations2010: 204 citations2011: 236 citations2012: 312 citations2013: 472 citations2014: 499 citations2015: 532 citations2016: 552 citations2017: 664 citations2018: 783 citations2019: 2,226 citations2020: 3,093 citations2021: 3,643 citations2022: 3,927 citations2023: 4,037 citations2024: 6,855 citations2025: 4,848 citations2026: 571 citations2027: 2 citations1970: no citations, so this year is not shown1972–1978: no citations, so these years are not shown1980–1983: no citations, so these years are not shown1985–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 14,558 citing papers, 32.3% of this breakdownUnited States: 7,290 citing papers, 16.2% of this breakdownUnited Kingdom: 1,876 citing papers, 4.2% of this breakdownGermany: 1,495 citing papers, 3.3% of this breakdownIndia: 1,325 citing papers, 2.9% of this breakdownItaly: 1,312 citing papers, 2.9% of this breakdownCanada: 1,129 citing papers, 2.5% of this breakdownAustralia: 1,102 citing papers, 2.4% of this breakdownSouth Korea: 1,071 citing papers, 2.4% of this breakdownFrance: 992 citing papers, 2.2% of this breakdownJapan: 901 citing papers, 2% of this breakdownSpain: 773 citing papers, 1.7% of this breakdown
0%32.3%Other 25%

Fields

  • Medicine25.4%
  • Biochemistry, Genetics and Molecular Biology24%
  • Engineering14%
  • Computer Science10.7%
  • Neuroscience5.2%
  • Materials Science3.5%
  • Other17.2%

Topics

  • MicroRNA in disease regulation1.6%
  • Nanoplatforms for cancer theranostics1.4%
  • HER2/EGFR in Cancer Research1%
  • Cancer-related molecular mechanisms research1%
  • RNA Interference and Gene Delivery1%
  • Cancer Immunotherapy and Biomarkers0.9%
  • Other93.1%

Coauthors

All papers

Open in search
  1. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dhiraj Gambhire, Lotus Yung, Yibin Wang, Jasmeet Singh, Patrik Vitazka, Gerold Meinhardt, Nadia Harbeck, David Cameron - New England Journal of Medicine 2022 cited by 2,548

  2. Decentralized Federated Averaging

    Authors: , , - IEEE Transactions on Pattern Analysis and Machine Intelligence, IEEE Trans. Pattern Anal. Mach. Intell. 2022 cited by 328

  3. Artificial intelligence for geoscience: Progress, challenges, and perspectives

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hongsheng Zhang, Shuai Yin, Ni Huang, Wei Zhao, Nan Li, Chaolei Zheng, Yang Zhou, Changping Huang, Defeng Feng, Qingsong Xu, Yan Wu, Danfeng Hong, Zhenyu Wang, Yinyi Lin, Tangtang Zhang, Prashant Kumar, Antonio Plaza, Jocelyn Chanussot, Jiabao Zhang, Jiancheng Shi, Lizhe Wang, Lizhe Wang, Lizhe Wang - The Innovation 2024 cited by 322

  4. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment

    Authors: , , , , , , , , , , , , , , , - Chinese Chemical Letters 2022 cited by 503

  5. Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela Girvin, James Greger, Dawn Millington, Monica Withelder, John Xie, Tao Sun, Shalin Shah, B. Diorio, Roland E. Knoblauch, Joshua Bauml, Rosario García Campelo, Byoung Chul Cho - Annals of Oncology 2023 cited by 396

  6. Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion

    Authors: , , , , , , , , , , , , , , , , , , - Nature Immunology 2019 cited by 535

  7. SHIFT: A Synthetic Driving Dataset for Continuous Multi-Task Domain Adaptation

    Authors: , , , , , , , - IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) 2022 cited by 176

  8. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J Feng, Min Yan, Yan Wang, Qiang Liu, S. Zhang, Michelino De Laurentiis, Armando Santoro, Valentina Guarneri, Marco Colleoni, Clara Natoli, Laura Cortesi, Sabino De Placido, Lorenzo Gianni, Francesco Ferraù, Lorenzo Livi, Alberto Zambelli, Lucia Del Mastro, Giuseppe Tonini, Filippo Montemurro, Giulia Bianchi, R. Pedersini, Salvatore A. Del Prete, Giacomo Allegrini, Giuseppe Naso, Patrizia Vici, D. Loirat, Audrey Mailliez, Franck Priou, Olivier Trédan, F. Dalenc, Christophe Perrin, Joseph Gligorov, Morales-Pancorbo David, Nadine Dohollou, Luís Teixeira, Fabien Brocard, Antoine Arnaud, Suzette Delaloge, Jean‐Philippe Spano, Luigi Mansi, Livia Andrade, Fernanda Damian, José Luiz Pedrini, Sandra M. Aleixo, Roberto Hegg, R. Junior, Mattea Reinisch, Marcus Schmidt, C. Wenzel, E.‐M. Grischke, Andreas Schneeweiß, Marianne Just, Nadia Harbeck, Claudia Schumacher, Ubong Peters, Dorothea Fischer, Helmut Forstbauer, Rüdiger Liersch, Ellen Warner, Nathaniel Bouganim, C. T. Doyle, Julie Price Hiller, Ted Vandenberg, Michel Pavic, Andrew Robinson, Gloria Roldan Urgoiti, Nadia Califaretti, Ahmet Alacacıoğlu, M. Gumus, Bülent Yalçın and 68 more - Annals of Oncology 2021 cited by 729

  9. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment

    Authors: , , , , , , , , , , , , - Biomaterials 2020 cited by 451

  10. Space-air-ground integrated network (SAGIN) for 6G: Requirements, architecture and challenges

    Authors: , , , , , , , , - China Communications 2022 cited by 219

  11. Antibody targeting of E3 ubiquitin ligases for receptor degradation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Seth F. Harris, Laëtitia Comps‐Agrar, Dhaya Seshasayee, Frédéric J. de Sauvage, Matthew Grimmer, Jing Li, Nicholas J. Agard, Felipe de Sousa e Melo - Nature 2022 cited by 255

  12. Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniil Stroyakovskiy, Marina Peregudova, Mehmet Alı Nahıt Şendur, Ozan Yazıcı, Raffaele Califano, Vanesa Gutiérrez Calderón, Filippo de Marinis, Antonio Passaro, Sang‐We Kim, Shirish M. Gadgeel, John Xie, Tao Sun, Melissa Martínez, Mariah Ennis, E. Fennema, Mahesh Daksh, Dawn Millington, Isabelle Leconte, Ryota Iwasawa, Patricia Lorenzini, Mahadi Baig, Sujay Shah, Joshua Bauml, S. Martin Shreeve, Seema Sethi, R.E. Knoblauch, Hidetoshi Hayashi - New England Journal of Medicine 2024 cited by 375

  13. OWL: Optimized Workforce Learning for General Multi-Agent Assistance in Real-World Task Automation

    Authors: , , , , , , , , , , , , , , , - ArXiv.org, CoRR 2025 cited by 85

  14. Macrophage‐Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke

    Authors: , , , , , , , , , , , , , , , , , , , , - Advanced Science 2021 cited by 314

  15. Cysteine cathepsins: From structure, function and regulation to new frontiers

    Authors: , , , , , , - Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2011 cited by 1,361

  16. Detection and diagnosis of chronic kidney disease using deep learning-based heterogeneous modified artificial neural network

    Authors: , , , - Future Generation Computer Systems, Future Gener. Comput. Syst. 2020 cited by 267

  17. Single-cell mapping of lineage and identity in direct reprogramming

    Authors: , , , , , , - Nature 2018 cited by 421

  18. Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy

    Authors: , , , , , , , , , , , , , - Nano Letters 2018 cited by 436

  19. Seed-Coder: Let the Code Model Curate Data for Itself

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - ArXiv.org, CoRR 2025 cited by 62

  20. Sequentially Triggered Bacterial Outer Membrane Vesicles for Macrophage Metabolism Modulation and Tumor Metastasis Suppression

    Authors: , , , , , , , , , , , , , , , , , , , - ACS Nano 2021 cited by 140

  21. Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate

    Authors: , , , , , , , , - Nature Communications 2022 cited by 201

  22. Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xiaoyu Zhu, Chunxia Chen, Jianjun Zou - The Lancet Oncology 2021 cited by 393

  23. McEval: Massively Multilingual Code Evaluation

    Authors: , , , , , , , , , , , , , , , , , , - ICLR 2025 cited by 57

  24. Current Status of Therapeutic Approaches against Peripheral Nerve Injuries: A Detailed Story from Injury to Recovery

    Authors: , , , , , , , , , , - International Journal of Biological Sciences 2019 cited by 307